SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 80 filers reported holding SAVARA INC in Q4 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,847 | -21.5% | 13,187 | -33.7% | 0.00% | – |
| Q2 2023 | $63,510 | +92.5% | 19,878 | +79412.0% | 0.00% | – |
| Q1 2022 | $33,000 | -50.0% | 25 | -47.9% | 0.00% | – |
| Q3 2021 | $66,000 | -99.5% | 48 | -99.3% | 0.00% | – |
| Q2 2021 | $12,282,000 | -69.9% | 7,225 | -63.2% | 0.00% | – |
| Q1 2021 | $40,843,000 | +326.3% | 19,636 | +135.7% | 0.00% | – |
| Q4 2020 | $9,580,000 | -15.9% | 8,330 | -20.3% | 0.00% | – |
| Q3 2020 | $11,390,000 | +43.9% | 10,450 | +228.7% | 0.00% | – |
| Q2 2020 | $7,916,000 | -70.7% | 3,179 | -75.1% | 0.00% | – |
| Q1 2020 | $27,022,000 | +28.7% | 12,746 | +171.9% | 0.00% | – |
| Q4 2019 | $20,998,000 | +66.5% | 4,687 | -1.5% | 0.00% | – |
| Q3 2019 | $12,609,000 | +65.7% | 4,758 | +48.2% | 0.00% | – |
| Q2 2019 | $7,610,000 | -82.7% | 3,211 | -46.3% | 0.00% | – |
| Q1 2019 | $44,036,000 | +383.0% | 5,975 | +631.3% | 0.00% | – |
| Q3 2018 | $9,118,000 | -1.4% | 817 | 0.0% | 0.00% | – |
| Q2 2018 | $9,248,000 | – | 817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 3,313,602 | $12,525,416 | 47.59% |
| NEA Management Company, LLC | 24,471,264 | $92,501,378 | 7.14% |
| Bain Capital Life Sciences Investors, LLC | 14,232,751 | $53,799,799 | 6.02% |
| TCG Crossover Management, LLC | 10,000,000 | $37,800,000 | 5.57% |
| VR Adviser, LLC | 7,184,865 | $27,158,790 | 2.86% |
| Affinity Asset Advisors, LLC | 1,150,000 | $4,347,000 | 1.22% |
| Sio Capital Management, LLC | 896,250 | $3,387,825 | 1.05% |
| Frazier Life Sciences Management, L.P. | 4,000,000 | $15,120,000 | 1.00% |
| Vivo Capital, LLC | 1,913,349 | $7,232,459 | 0.79% |
| Nantahala Capital Management | 1,039,364 | $3,928,796 | 0.34% |